Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Quantum Genomics
Quantum Genomics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Quantum Genomics
Stock Price
€0.1
2024-10-29
Market Capitalization
€2.5 M
2024-10-29
Quantum Genomics Summary
Company Summary
Overview
Quantum Genomics is a biopharmaceutical company. It is engaged in the research and development of drugs for the treatment of cardiovascular diseases. The company develops drugs primarily to treat high blood pressure and heart failure.
Type
Public
Status
Active
Founded
2006
HQ
Paris, FR
|
view all locations
Website
http://www.quantum-genomics.com/www/en/
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
healthtech
pharma
Homepage
Linkedin
twitter
Table of Contents
Key People
Locations
Financials
Competitors
Key People
Carole Wassermann,
Director
Fabrice Balavoine,
Vice President Research and Development
Linkedin
Benoît Gueugnon,
Director, Administratif, Financier
Linkedin
Frederic Duchesne,
Director
and 1 others
Locations
View all
1 location detected
Paris, IDF
HQ
France
33 Rue Marbeuf
Quantum Genomics Financials
Summary Financials
Net income (FY, 2024)
(€8.9M)
Cash (FY, 2024)
€301.0K
EBIT (FY, 2024)
(€1.5M)
Enterprise value
$4.8M
Competitors and Similar Companies
Innovent Biologics
Healthcare - Private
Taiwan Liposome
Healthcare - Private
Orca Bio
Healthcare - Private
Sanofi Genzyme
Healthcare - Subsidiary
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top